Market

In addition to their use in diabetes, injection systems can be applied in, for example, the treatment of anaemia, hepatitis, infertility, osteoporosis, psoriasis, rheumatoid arthritis, thrombosis, and growth disorders, as well as for the administration of hormone therapy. Many substances now in the pipelines of pharmaceutical and biotech companies are manufactured biotechnically and consequently have to be administered in most cases by injection. This means that the need for customer-specific injection systems should increase in the future.

The overall market is growing steadily due to increasingly ageing populations in industrial countries.
The rapid rise of diabetes is not only taking place in industrialised countries, it is also spreading increasingly in emerging and developing countries. India, China and numerous other Asian countries are particularly hard hit and have an increasing need for insulin. The number of diabetics is increasing worldwide at a rate of around 3% a year, and growth in the insulin market stands at over 10%.